Experimental and Molecular Medicine (Apr 2024)

Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression

  • Yeajina Lee,
  • Tamrin Chowdhury,
  • Sojin Kim,
  • Hyeon Jong Yu,
  • Kyung-Min Kim,
  • Ho Kang,
  • Min-Sung Kim,
  • Jin Wook Kim,
  • Yong-Hwy Kim,
  • So Young Ji,
  • Kihwan Hwang,
  • Jung Ho Han,
  • Jinha Hwang,
  • Seong-Keun Yoo,
  • Kyu Sang Lee,
  • Gheeyoung Choe,
  • Jae-Kyung Won,
  • Sung-Hye Park,
  • Yong Kyu Lee,
  • Joo Heon Shin,
  • Chul-Kee Park,
  • Chae-Yong Kim,
  • Jong-Il Kim

DOI
https://doi.org/10.1038/s12276-024-01204-3
Journal volume & issue
Vol. 56, no. 4
pp. 975 – 986

Abstract

Read online

Abstract We explored the genomic events underlying central neurocytoma (CN), a rare neoplasm of the central nervous system, via multiomics approaches, including whole-exome sequencing, bulk and single-nuclei RNA sequencing, and methylation sequencing. We identified FGFR3 hypomethylation leading to FGFR3 overexpression as a major event in the ontogeny of CN that affects crucial downstream events, such as aberrant PI3K-AKT activity and neuronal development pathways. Furthermore, we found similarities between CN and radial glial cells based on analyses of gene markers and CN tumor cells and postulate that CN tumorigenesis is due to dysregulation of radial glial cell differentiation into neurons. Our data demonstrate the potential role of FGFR3 as one of the leading drivers of tumorigenesis in CN.